Primary Curative Therapy for Head and Neck Squamous Cell Carcinoma with Cetuximab in Combination with Radiation

This is a clinical practice guideline that facilitates the safe and effective clinical use of cetuximab in combination with radiation as the primary curative therapy for head and neck squamous cell carcinoma in the adult population. This guidelines specifically considers patients with contraindications to platinum based chemotherapy and/or those over the age of 70.